glp-1 agonist and pancreatitis Suspected drug-induced was rare but more common in patients taking agonists than sulfonylureas, a recent analysis of a VA database finds Pancreatitis Warnings Strengthened on GLP-1RAs
Description
However, the precise mechanisms underlying their cardiovascular benefits remain to be fully elucidated

Nondigestible carbohydrates, butyrate, and butyrate-producing bacteria
JAMA 330, 17951797

doi: 10.1016/s0167-0115(02)00157-x

Ethics declarations Competing interests All authors are employees of Heptares Therapeutics Ltd and are shareholders in Sosei Group Corporation
